Brigham and Women's Hospital, in collaboration with the Dana-Farber Cancer Institute, studies the efficacy of Gemcitabine and Cisplatin chemotherapy administered in the operating room

From August 2nd to the 5th, a review of state-of-the-art imaging techniques was held at the Hyatt Regency Lake Tahoe Resort in Incline Village, Nevada

Leading hospital administrators and physicians specializing in cancer care gathered for a two-day symposium in Texas

The review held from July 29 through July 31 at the Ritz-Carlton on Amelia Island, Florida offers a comprehensive postgraduate course to update practicing hematologists/oncologists with practical developments

The study sponsored by Columbia University investigates the effects of different pharmaceuticals (Cisplatin, Doxorubicin, Pemetrexed) on mesothelioma survival rate

The review of therapeutic strategies for the treatment of kidney, bladder and prostate cancers was held from July 15-16 at the Fairmont, Washington, DC.

Solid tumor and hematologic malignancies treatment among topics of discussion at the recent Philadelphia symposium

Nationally recognized physicians to present a three-day program concerning management of common cancers and patients under treatment

Lung cancer and mesothelioma treatment to be debated in July at Lung Cancer Congress in California

Two-day symposium on the option of using the immune system to fight mesothelioma will be held in Boston

The Multinational Association of Supportive Care in Cancer will bring together health professionals from various countries today until Saturday to discuss all aspects of cancer treatment

A study sponsored by the National Cancer Institute and located in Bethesda, Maryland may lead to critical developments in the treatment of mesothelioma disease

Meeting will bring together oncologists, thoracic surgeons, and other healthcare professionals to discuss treatments for non-small cell lung cancer

Study sponsor Pfizer has completed a trial for patients with malignant mesothelioma and advanced solid tumors in the United States and Canada

Money raised as a result of a ten-week fundraising event, which wraps up on June 15th, will go towards the Leukemia & Lymphoma Society’s research efforts

A study sponsored by Memorial Sloan-Kettering Cancer Center in collaboration with Novartis Pharmaceuticals may lead to critical developments in the treatment of mesothelioma

Each year, cancer survivors are celebrated with events nationwide, and the National Cancer Survivors Day Foundation assists people with event organization at no charge

Physicians to gather for ASCO’s 2010 annual meeting to share research on cancer development and further knowledge of cancer treatment

Sponsor Columbia University launches a trial for patients with malignant pleural or peritoneal mesothelioma

Sponsor Dana-Farber Cancer Institute, in collaboration with Massachusetts General Hospital and the University of Chicago, has wrapped up a trial for patients with malignant mesothelioma